# TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis

> **NCT00001862** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 15 (—)

## Conditions studied

- Juvenile Rheumatoid Arthritis
- Uveitis

## Interventions

- **DRUG:** Enbrel

## Key facts

- **NCT ID:** NCT00001862
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 15 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001862, "TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*